Individual research projects
Right now, we’re funding around 100 cutting-edge projects worth almost £32 million. All to discover how we can prevent and diagnose breast cancer earlier, find better treatments, and improve people's quality of life.
Our research projects
Cell Death and Immunity team
Professor Pascal Meier
Designing new potent chemotherapy drugs that exclusively kill cancer cells
Dr Robert Falconer
Antibody therapy and biomarker discovery team
Professor Sophia Karagiannis
Cancer Bioinformatics Team
Professor Anita Grigoriadis
Target validation and DNA damage response team
Professor Andrew Tutt
Developing a vaccine treatment for triple negative breast cancer
Dr Niamh Buckley
Functional Genomics Team
Dr Rachael Natrajan
Gene Function team
Professor Chris Lord
Finding ways to make triple negative breast cancer more sensitive to chemotherapy
Professor Richard Clarkson
Understanding the role of changing oxygen levels in triple negative breast cancer
Professor Ester Hammond
Researching the potential of PLK inhibitors to treat breast cancer
Professor Ross Chapman